Carolyn Soo, PharmD is Vice President of Clinical Operations at Morphic Therapeutic.  She has 19 years of experience in the clinical setting and pharmaceutical industry, including extensive drug development experience in multiple therapeutic areas including neurology, immunology, ophthalmology, and rare diseases. Prior to joining Morphic, Carolyn was Executive Director of Clinical Operations at Aldeyra Therapeutics and has held position at Shire, Dyax, and Sunovion in areas such as Clinical Development and Operations and Medical Affairs. Carolyn has a PharmD from Northeastern University and worked as an investigational pharmacist at Brigham and Women’s Hospital prior to joining the industry.